ValuEngine upgraded shares of Anthem (NYSE:ANTM) from a hold rating to a buy rating in a research note released on Tuesday.
Several other analysts have also weighed in on ANTM. Barclays initiated coverage on Anthem in a report on Thursday, March 8th. They set an overweight rating and a $270.00 price target on the stock. Zacks Investment Research lowered Anthem from a buy rating to a hold rating in a research note on Tuesday, April 3rd. Cantor Fitzgerald reiterated a buy rating and issued a $275.00 target price on shares of Anthem in a research note on Wednesday, April 25th. JPMorgan Chase & Co. upgraded Anthem from a neutral rating to an overweight rating in a research note on Thursday, April 26th. Finally, Sanford C. Bernstein set a $332.00 target price on Anthem and gave the stock an outperform rating in a research note on Thursday, April 26th. Four research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Anthem has an average rating of Buy and an average target price of $254.08.
NYSE:ANTM opened at $238.03 on Tuesday. Anthem has a fifty-two week low of $179.40 and a fifty-two week high of $267.95. The firm has a market cap of $61.39 billion, a P/E ratio of 19.77, a P/E/G ratio of 1.34 and a beta of 0.84. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.49 and a current ratio of 1.49.
Anthem (NYSE:ANTM) last released its quarterly earnings results on Wednesday, April 25th. The company reported $5.41 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $4.83 by $0.58. Anthem had a return on equity of 12.77% and a net margin of 4.60%. The company had revenue of $22.34 billion for the quarter, compared to analyst estimates of $22.55 billion. During the same quarter in the prior year, the firm posted $4.68 EPS. Anthem’s quarterly revenue was up .1% compared to the same quarter last year. sell-side analysts forecast that Anthem will post 15.39 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Monday, June 25th. Stockholders of record on Friday, June 8th were paid a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, June 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.26%. Anthem’s dividend payout ratio is currently 24.92%.
In other news, Director Robert L. Dixon, Jr. sold 1,000 shares of the firm’s stock in a transaction on Friday, May 18th. The stock was sold at an average price of $231.10, for a total transaction of $231,100.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Brian T. Griffin sold 59,421 shares of the firm’s stock in a transaction on Thursday, May 3rd. The shares were sold at an average price of $224.41, for a total value of $13,334,666.61. Following the transaction, the chief executive officer now owns 25,619 shares in the company, valued at approximately $5,749,159.79. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 61,421 shares of company stock worth $13,798,767. Insiders own 0.31% of the company’s stock.
Several institutional investors have recently made changes to their positions in the company. Mount Yale Investment Advisors LLC purchased a new position in shares of Anthem during the first quarter valued at $632,000. Dynamic Technology Lab Private Ltd increased its stake in shares of Anthem by 156.3% during the first quarter. Dynamic Technology Lab Private Ltd now owns 4,100 shares of the company’s stock valued at $901,000 after buying an additional 2,500 shares during the period. 180 Wealth Advisors LLC purchased a new position in shares of Anthem during the first quarter valued at $258,000. Suntrust Banks Inc. increased its stake in shares of Anthem by 15.1% during the first quarter. Suntrust Banks Inc. now owns 45,048 shares of the company’s stock valued at $9,896,000 after buying an additional 5,911 shares during the period. Finally, Trilogy Capital Inc. purchased a new position in shares of Anthem during the first quarter valued at $428,000. Hedge funds and other institutional investors own 87.50% of the company’s stock.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.